| NCT ID | NCT02154776 |
| Title | Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. (LeeBLet) |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |